LAKE ZURICH, IL, UNITED STATES, March 17, 2026 /EINPresswire.com/ -- The Sikh community in the United States, estimated ...

Greenwich LifeSciences has added City of Hope to its Phase III FLAMINGO-01 clinical trial, which is investigating the GLSI-100 immunotherapy for preventing breast cancer recurrenc ...

Partnership will enhance physician awareness of START's portfolio of trials, streamline referrals, and support patient access to early-phase oncology research SAN ANTONIO and BARCELONA, Spain, March ...

Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer MORRISTOWN, NJ, ...

Clinical trials are widely accepted as the way to progress toward establishing new standards in cancer therapies while simultaneously offering affordable, state-of-the-art care. But few people ...

Despite the many benefits of clinical trials, misconceptions still exist. Get the facts, so you can make an informed choice about whether applying for a trial is right for you. Whether you are at the ...

Clinical trial led by UAB researcher supports approval of new, potentially curative treatment for multiple myeloma ...

START will leverage Trialing’s platform to distribute curated information on ongoing early-phase oncology trials.

A new clinical trial led by the Alliance for Clinical Trials in Oncology will investigate if a combination of drug therapies after radiation therapy improves outcomes for people with newly-diagnosed, ...

SUCCEED trial enables remote participation for small cell lung cancer patients, addressing location barriers and enhancing research opportunities. NXP800 shows promise in recurrent, platinum-resistant ...

Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of cancers, today announced that the Company will ...

Simon Spichak finished his MSc at University College Cork, where he studied the interactions between the microbes in the gut and the brain. He became interested in science communication during his ...